Critical Considerations: This schedule is purely theoretical and not based on clinical evidence Individual tolerance varies dramaticallysome may not tolerate even these conservative doses Maximum combined doses would likely need to remain below monotherapy maximums (perhaps 2.4 mg cagrilintide + 8 mg retatrutide as absolute ceiling) Medical supervision would be essential throughout any such protocol Alternative Approach: Sequential Rather Than Concurrent An arguably safer alternative to simultaneous cagrilintide dosage with retatrutide administration involves sequential optimization: Optimize one compound first Reach stable, effective dose of either cagrilintide or retatrutide Assess response Evaluate metabolic effects over 12-16 weeks Introduce second compound Only if additional effects are needed Ultra-gradual second titration Even slower escalation of the added compound Continuous reassessment Regular evaluation of whether combination provides benefits beyond monotherapy This approach provides clearer attribution of effects and side effects to specific compounds, though it significantly extends the overall timeline
4 Four of the most critical are: Aging defense Antioxidant protection Detoxification Energy production Glutathione is also responsible for: Cysteine carrier/storage Cell signaling Enzyme function Gene expression Cell differentiation/proliferation Thats a lot of complicated medical and biochemical jargon that means, in short, the antioxidant properties of glutathione work to improve communication between the cells, stabilize and reduce oxidation in the cells, fight free radical damage, support protein function, and take out the cellular trash
Notably, the combination of autophagy inhibitors (such as chloroquine) and ferroptosis inducers (such as erastin) can significantly inhibit breast cancer proliferation, suggesting the potential of synergistic therapy for dual death pathways [114]
This is why GHK-Cu cycling exists typically 30-60 days on, equal time off
